Vaxart Operating Income from 2010 to 2024

VXRT Stock

USD 0.61 0.02 3.17%

Vaxart Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Vaxart Inc generates from its operations. View All Fundamentals

Operating Income

First Reported

1985-09-30

Previous Quarter

-16.3 M

Current Value

-14.5 M

Quarterly Volatility

14.3 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 M, Interest Expense of 1.4 M or Total Revenue of 7 M, as well as many indicators such as Price To Sales Ratio of 10.68, Dividend Yield of 0.0 or PTB Ratio of 2.34. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.

Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Operating Income Growth Pattern

Below is the plot of the Operating Income of Vaxart Inc over the last few years. Operating Income is the amount of profit realized from Vaxart Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Vaxart Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Vaxart's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Vaxart Operating Income Regression Statistics

	Arithmetic Mean	(36,742,577)
	Geometric Mean	24,275,995
	Coefficient Of Variation	(91.71)
	Mean Deviation	27,052,712
	Median	(22,100,000)
	Standard Deviation	33,695,967
	Sample Variance	1135.4T
	Range	116.2M
	R-Value	(0.82)
	Mean Square Error	400.9T
	R-Squared	0.67
	Significance	0.0002
	Slope	(6,177,309)
	Total Sum of Squares	15895.9T

Vaxart Operating Income History

	2024	-79.2 M
	2023	-83.3 M
	2022	-114.6 M
	2021	-72.8 M
	2020	-30.2 M
	2019	-15.8 M
	2018	-21.8 M

Other Fundumenentals of Vaxart Inc

Non Operating Income Net Other

Vaxart Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	-0.64	-0.53	-0.1	0.65	0.85	0.27	0.09	0.04	-0.41	-0.04	0.35	-0.32	0.8	-0.23	0.53	-0.23	0.48	-0.03	0.48	-0.24	0.88	0.83	-0.48
Total Stockholder Equity	0.98		-0.73	-0.37	-0.01	0.48	0.91	0.11	0.07	0.12	-0.36	-0.03	0.37	-0.22	0.83	-0.25	0.43	-0.27	0.58	0.06	0.35	-0.25	0.87	0.89	-0.48
Net Debt	-0.64	-0.73		-0.13	-0.13	-0.14	-0.91	0.34	-0.01	-0.1	-0.13	0.3	-0.01	0.06	-0.55	0.22	0.02	0.17	-0.61	0.03	0.29	0.21	-0.48	-0.71	0.26
Retained Earnings	-0.53	-0.37	-0.13		0.4	-0.84	-0.15	-0.83	-0.01	0.25	0.44	-0.05	-0.2	0.57	-0.38	-0.04	-0.75	-0.06	0.2	0.11	-0.89	-0.03	-0.48	-0.19	0.34
Net Receivables	-0.1	-0.01	-0.13	0.4		-0.43	0.05	-0.34	-0.39	0.24	0.3	-0.28	-0.09	0.01	-0.03	-0.25	-0.39	-0.61	0.38	0.38	-0.25	-0.24	-0.42	-0.27	0.08
Total Liab	0.65	0.48	-0.14	-0.84	-0.43		0.35	0.62	0.17	-0.28	-0.38	-0.11	0.21	-0.54	0.37	-0.07	0.63	0.04	-0.09	-0.38	0.66	-0.08	0.54	0.32	-0.25
Total Current Assets	0.85	0.91	-0.91	-0.15	0.05	0.35		-0.19	-0.05	0.14	-0.04	-0.18	0.36	-0.16	0.71	-0.19	0.19	-0.22	0.6	0.02	0.03	-0.19	0.69	0.84	-0.42
Short Term Debt	0.27	0.11	0.34	-0.83	-0.34	0.62	-0.19		0.11	-0.25	-0.49	0.26	-0.2	-0.37	0.3	-0.14	0.79	0.14	-0.34	-0.17	0.85	-0.14	0.31	0.0	-0.3
Intangible Assets	0.09	0.07	-0.01	-0.01	-0.39	0.17	-0.05	0.11		-0.27	-0.7	-0.11	-0.32	-0.09	0.06	-0.13	-0.04	0.01	-0.09	-0.13	-0.01	-0.14	0.34	0.24	0.35
Accounts Payable	0.04	0.12	-0.1	0.25	0.24	-0.28	0.14	-0.25	-0.27		0.04	0.15	0.3	0.04	0.17	-0.17	-0.11	-0.34	0.42	-0.12	0.02	-0.17	0.0	0.12	-0.14
Common Stock	-0.41	-0.36	-0.13	0.44	0.3	-0.38	-0.04	-0.49	-0.7	0.04		-0.14	-0.05	0.27	-0.42	0.15	-0.37	0.28	-0.06	0.14	-0.6	0.16	-0.62	-0.39	-0.04
Good Will	-0.04	-0.03	0.3	-0.05	-0.28	-0.11	-0.18	0.26	-0.11	0.15	-0.14		0.19	0.66	0.33	-0.14	0.57	0.49	-0.03	-0.19	0.27	-0.14	0.25	0.22	-0.21
Short Term Investments	0.35	0.37	-0.01	-0.2	-0.09	0.21	0.36	-0.2	-0.32	0.3	-0.05	0.19		-0.02	0.21	0.18	0.11	-0.14	0.19	0.03	0.29	0.18	0.34	0.33	-0.31
Current Deferred Revenue	-0.32	-0.22	0.06	0.57	0.01	-0.54	-0.16	-0.37	-0.09	0.04	0.27	0.66	-0.02		-0.05	-0.08	-0.03	0.52	-0.07	0.08	-0.47	-0.08	-0.09	0.09	0.14
Net Tangible Assets	0.8	0.83	-0.55	-0.38	-0.03	0.37	0.71	0.3	0.06	0.17	-0.42	0.33	0.21	-0.05		-0.47	0.66	-0.13	0.52	-0.07	0.46	-0.48	0.8	0.83	-0.44
Long Term Debt	-0.23	-0.25	0.22	-0.04	-0.25	-0.07	-0.19	-0.14	-0.13	-0.17	0.15	-0.14	0.18	-0.08	-0.47		-0.33	0.05	-0.17	-0.06	-0.09	1.0	-0.12	-0.22	-0.01
Capital Surpluse	0.53	0.43	0.02	-0.75	-0.39	0.63	0.19	0.79	-0.04	-0.11	-0.37	0.57	0.11	-0.03	0.66	-0.33		0.36	-0.08	-0.18	0.77	-0.34	0.59	0.42	-0.43
Deferred Long Term Liab	-0.23	-0.27	0.17	-0.06	-0.61	0.04	-0.22	0.14	0.01	-0.34	0.28	0.49	-0.14	0.52	-0.13	0.05	0.36		-0.54	0.0	-0.12	0.05	0.0	0.0	0.01
Long Term Investments	0.48	0.58	-0.61	0.2	0.38	-0.09	0.6	-0.34	-0.09	0.42	-0.06	-0.03	0.19	-0.07	0.52	-0.17	-0.08	-0.54		-0.13	-0.07	-0.17	0.35	0.48	-0.15
Short Long Term Debt	-0.03	0.06	0.03	0.11	0.38	-0.38	0.02	-0.17	-0.13	-0.12	0.14	-0.19	0.03	0.08	-0.07	-0.06	-0.18	0.0	-0.13		-0.12	-0.07	-0.1	-0.04	0.0
Property Plant Equipment	0.48	0.35	0.29	-0.89	-0.25	0.66	0.03	0.85	-0.01	0.02	-0.6	0.27	0.29	-0.47	0.46	-0.09	0.77	-0.12	-0.07	-0.12		-0.1	0.49	0.18	-0.39
Long Term Debt Total	-0.24	-0.25	0.21	-0.03	-0.24	-0.08	-0.19	-0.14	-0.14	-0.17	0.16	-0.14	0.18	-0.08	-0.48	1.0	-0.34	0.05	-0.17	-0.07	-0.1		-0.12	-0.22	-0.01
Net Invested Capital	0.88	0.87	-0.48	-0.48	-0.42	0.54	0.69	0.31	0.34	0.0	-0.62	0.25	0.34	-0.09	0.8	-0.12	0.59	0.0	0.35	-0.1	0.49	-0.12		0.92	-0.42
Net Working Capital	0.83	0.89	-0.71	-0.19	-0.27	0.32	0.84	0.0	0.24	0.12	-0.39	0.22	0.33	0.09	0.83	-0.22	0.42	0.0	0.48	-0.04	0.18	-0.22	0.92		-0.41
Capital Stock	-0.48	-0.48	0.26	0.34	0.08	-0.25	-0.42	-0.3	0.35	-0.14	-0.04	-0.21	-0.31	0.14	-0.44	-0.01	-0.43	0.01	-0.15	0.0	-0.39	-0.01	-0.42	-0.41

Click cells to compare fundamentals

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-83.3 M	-79.2 M
Non Operating Income Net Other	-5.4 K	-5.1 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaxart Operating Income from 2010 to 2024

Latest Vaxart's Operating Income Growth Pattern

Vaxart Operating Income Regression Statistics

Vaxart Operating Income History

Other Fundumenentals of Vaxart Inc

Vaxart Operating Income component correlations

About Vaxart Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Vaxart Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY